These results strongly suggest that JQ1-mediated activation of Nrf2 facilitates cell survival and that ATRA may promote the cytotoxicity of JQ1 by interfering with Nrf2 and increasing ROS levels in SCLC cells. Here, NFE2L2 is linked to small cell lung carcinoma.